Recent Updates
Recently added Catalysts
HYPR Positive Sentiment

Hyperfine to Present at the Piper Sandler 38th Annual Healthcare Conference on December 3

Key Takeaway: Hyperfine, Inc. will present at the Piper Sandler 38th Annual Healthcare Conference on December 3, 2026. The company will showcase its FDA-cleared Swoop® portable MRI system for brain imaging. Management will also hold in-person investor meetings during the conference. A live webcast will be available for those unable to attend.

Market Sentiment Analysis

POSITIVE FACTORS

  • Hyperfine will present at a major healthcare conference.
  • The Swoop® system is the first FDA-cleared portable MRI.
  • Management will host investor meetings at the event.

Full Press Release Details

Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced that management will present at the Piper Sandler 38th Annual Healthcare Conference in New York on Thursday, December 3, 2026 at 9:10 a.m. Eastern Time. Management will also host in-person investor meetings at the conference.
A live webcast, as well as an archived recording, will be available on the “Investors” section of the Company’s website at: https://investors.hyperfine.io/. The webcast will be archived and available for replay for at least 90 days after the event.
To schedule a one-on-one meeting with Hyperfine management, please reach out to your Piper Sandler representative, or the investor contact below.
About the Swoop® Portable MRI Systems
The Swoop® Portable MR Imaging® Systems are U.S. Food and Drug Administration (FDA) cleared for brain imaging of patients of all ages. They are portable, ultra-low-field magnetic resonance imaging devices for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.
About Hyperfine, Inc.
Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking health technology company that has redefined brain imaging with the Swoop® system—the first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of professional care. The mission of Hyperfine, Inc. is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging. Founded by Dr. Jonathan Rothberg in a technology-based incubator called 4Catalyzer, Hyperfine, Inc. scientists, engineers, and physicists developed the Swoop® system out of a passion for redefining brain imaging methodology and how clinicians can apply accessible diagnostic imaging to patient care. For more information, visit HyperfineMRI.com.
The Hyperfine logo, Swoop, and Portable MR Imaging are registered trademarks of Hyperfine, Inc. The Swoop logo, Optive AI logo, and Optive AI are trademarks of Hyperfine, Inc.

Frequently Asked Questions

When will Hyperfine present at the conference?

Hyperfine will present on December 3, 2026, at 9:10 a.m. ET.

What is the Swoop® system?

The Swoop® system is an FDA-cleared portable MRI for brain imaging.

Where can I watch the presentation?

The presentation will be available via a live webcast on their website.

How can I schedule a meeting with Hyperfine management?

Contact your Piper Sandler representative to schedule a one-on-one meeting.

Last updated: Nov 19, 2026